[{"Assets_0_FY_USD":33707000000.0,"CommonStockDividendsPerShareDeclared_1_FY_USD":0.39,"CommonStockDividendsPerShareDeclared_4_FY_USD":1.53,"NetIncomeLoss_1_FY_USD":894000000.0,"NetIncomeLoss_4_FY_USD":4457000000.0,"StockholdersEquity_0_FY_USD":16177000000.0,"EarningsPerShareBasic_1_FY_USD":0.53,"EarningsPerShareBasic_4_FY_USD":2.67,"EarningsPerShareDiluted_1_FY_USD":0.53,"EarningsPerShareDiluted_4_FY_USD":2.65,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":2850000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1680000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1671000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365472986.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170221"}]